Abbott Laboratories (ABT)
123.45 x 1 127.03 x 1
Post-market by (Cboe BZX)
124.44 -7.19 (-5.46%) 04/04/25 [NYSE]
123.45 x 1 127.03 x 1
Post-market 125.00 +0.56 (+0.45%) 19:59 ET
for Fri, Apr 4th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ABT | BSX | SYK | ||
| Company | Abbott Laboratories | Boston Scientific Corp | Stryker Corp | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 131.23 | 94.73 | 361.08 | ||
| High | 132.40 | 95.89 | 362.07 | ||
| Low | 124.00 | 89.65 | 344.81 | ||
| Last | 124.44 | 89.70 | 345.80 | ||
| Change | -7.19 | -8.80 | -22.35 | ||
| % Change | -5.46% | -8.93% | -6.07% | ||
| Volume | 10,776,800 | 22,572,500 | 3,956,700 | ||
| 20-Day Average Volume | 7,188,205 | 8,940,625 | 1,790,055 | ||
| Previous Close | 131.63 | 98.50 | 368.15 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 129.27 | 98.91 | 369.46 | ||
| 20-Day Raw Stochastic | 2.90% | 0.34% | 2.74% | ||
| 20-Day Relative Strength | 42.12% | 33.29% | 34.28% | ||
| Weighted Alpha | +13.17 | +22.60 | -4.22 | ||
| Today's Opinion | 40% Buy | 8% Buy | 24% Sell | ||
| Previous Opinion | 72% Buy | 40% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.88% since 03/28/25 | -9.72% since 03/28/25 | -5.13% since 03/28/25 | ||
| Low | 124.00 on 04/04/25 | 89.65 on 04/04/25 | 344.81 on 04/04/25 | ||
| High | 133.64 on 04/03/25 | 101.28 on 04/01/25 | 378.35 on 04/02/25 | ||
| 1-Month | |||||
| %Chg | -9.55% since 03/04/25 | -13.43% since 03/04/25 | -11.32% since 03/04/25 | ||
| Low | 124.00 on 04/04/25 | 89.65 on 04/04/25 | 344.81 on 04/04/25 | ||
| High | 139.15 on 03/10/25 | 105.21 on 03/05/25 | 398.00 on 03/05/25 | ||
| 3-Month | |||||
| %Chg | +9.32% since 01/03/25 | -1.09% since 01/03/25 | -4.35% since 01/03/25 | ||
| Low | 110.86 on 01/15/25 | 89.65 on 04/04/25 | 344.81 on 04/04/25 | ||
| High | 141.23 on 03/04/25 | 107.17 on 02/05/25 | 406.19 on 01/28/25 | ||
| 6-Month | |||||
| %Chg | +10.48% since 10/04/24 | +6.10% since 10/04/24 | -1.54% since 10/04/24 | ||
| Low | 110.86 on 01/15/25 | 80.64 on 10/30/24 | 343.95 on 10/07/24 | ||
| High | 141.23 on 03/04/25 | 107.17 on 02/05/25 | 406.19 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 215,819,168 | 132,672,568 | 131,988,048 | ||
| Shares Outstanding, K | 1,734,323 | 1,479,070 | 381,689 | ||
| Annual Sales | 41,950,000,000 | 16,747,000,000 | 22,595,000,000 | ||
| Annual Net Income | 13,402,000,000 | 1,854,000,000 | 2,993,000,000 | ||
| Last Quarter Sales | 10,974,000,000 | 4,562,000,000 | 6,436,000,000 | ||
| Last Quarter Net Income | 9,229,000,000 | 568,000,000 | 546,000,000 | ||
| 60-Month Beta | 0.80 | 0.73 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.34 on 01/22/25 | 0.70 on 02/05/25 | 4.01 on 01/28/25 | ||
| Latest Earnings Date | 04/16/25 | 04/23/25 | 04/29/25 | ||
| Most Recent Dividend | 0.590 on 01/15/25 | N/A | 0.840 on 03/31/25 | ||
| Next Ex-Dividends Date | 04/15/25 | N/A | 03/31/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 28.19 | 39.24 | 30.20 | ||